FERRITIN VARIANTS WITH INCREASED STABILITY AND COMPLEXATION ABILITY
The present invention relates to a ferritin variant polypeptide, wherein at least one lysine residue is deleted or substituted with a non-basic amino acid. The invention further relates to a complex of this polypeptide and a label or drug, and an isolated cellular delivery system comprising the poly...
Saved in:
| Main Authors | , , , , , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
22.09.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to a ferritin variant polypeptide, wherein at least one lysine residue is deleted or substituted with a non-basic amino acid. The invention further relates to a complex of this polypeptide and a label or drug, and an isolated cellular delivery system comprising the polypeptide or the complex of the invention as well as uses of such system for prophylaxis, therapy, diagnosis or theragnosis, in particular for therapy of cancer or inflammatory diseases.
La présente invention concerne un polypeptide variant de ferritine, dans lequel au moins un résidu lysine est supprimé ou substitué par un acide aminé non basique. L'invention concerne en outre un complexe de ce polypeptide et d'une étiquette ou d'un médicament et un système d'administration cellulaire isolé comprenant le polypeptide ou le complexe de l'invention, ainsi que des utilisations de ce système pour la prophylaxie, la thérapie, le diagnostic ou la théragnostique, en particulier pour la thérapie d'un cancer ou de maladies inflammatoires. |
|---|---|
| AbstractList | The present invention relates to a ferritin variant polypeptide, wherein at least one lysine residue is deleted or substituted with a non-basic amino acid. The invention further relates to a complex of this polypeptide and a label or drug, and an isolated cellular delivery system comprising the polypeptide or the complex of the invention as well as uses of such system for prophylaxis, therapy, diagnosis or theragnosis, in particular for therapy of cancer or inflammatory diseases.
La présente invention concerne un polypeptide variant de ferritine, dans lequel au moins un résidu lysine est supprimé ou substitué par un acide aminé non basique. L'invention concerne en outre un complexe de ce polypeptide et d'une étiquette ou d'un médicament et un système d'administration cellulaire isolé comprenant le polypeptide ou le complexe de l'invention, ainsi que des utilisations de ce système pour la prophylaxie, la thérapie, le diagnostic ou la théragnostique, en particulier pour la thérapie d'un cancer ou de maladies inflammatoires. |
| Author | ARCOVITO, Alessandro BONAMORE, Alessandra BOFFI, Alberto SKORZYNSKI, Marcin KROL, Magdalena MARSZALEK, Ilona RYGIEL, Tomasz |
| Author_xml | – fullname: BONAMORE, Alessandra – fullname: MARSZALEK, Ilona – fullname: SKORZYNSKI, Marcin – fullname: KROL, Magdalena – fullname: BOFFI, Alberto – fullname: RYGIEL, Tomasz – fullname: ARCOVITO, Alessandro |
| BookMark | eNrjYmDJy89L5WRwdnMNCvIM8fRTCHMM8nT0CwlWCPcM8VDw9HMOcnUMdnVRCA5xdPL08QyJVHD0c1Fw9vcN8HGNcAzx9PdTgErwMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAyMjQ0tTA0sjR0Nj4lQBACEkLnY |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | VARIANTS DE FERRITINE AYANT UNE STABILITÉ ET UNE CAPACITÉ DE COMPLEXATION ACCRUES |
| ExternalDocumentID | WO2022195092A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_WO2022195092A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:55:21 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_WO2022195092A13 |
| Notes | Application Number: WO2022EP57205 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220922&DB=EPODOC&CC=WO&NR=2022195092A1 |
| ParticipantIDs | epo_espacenet_WO2022195092A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20220922 |
| PublicationDateYYYYMMDD | 2022-09-22 |
| PublicationDate_xml | – month: 09 year: 2022 text: 20220922 day: 22 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | CELLIS AG |
| RelatedCompanies_xml | – name: CELLIS AG |
| Score | 3.4303362 |
| Snippet | The present invention relates to a ferritin variant polypeptide, wherein at least one lysine residue is deleted or substituted with a non-basic amino acid. The... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | FERRITIN VARIANTS WITH INCREASED STABILITY AND COMPLEXATION ABILITY |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220922&DB=EPODOC&locale=&CC=WO&NR=2022195092A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1DeditMpAaVvxS5Lq30Y0qUpq2zt6Oo2n8aSpSBIN1zFv28aOt3T3pIcHJeDy33mDuChLTLMXYeYmSOwSZ5Jx1wsbdtsO5mU0lpYQqcLhpHTfyOvM3tWg8_tXxjdJ_RHN0dUEiWUvBf6vV7_B7F8XVu5eeQf6mj1EqRd36i8Y4wtF2PD73XZKPZjalCq_DYjSjSsnHjqYk_5SgelIV122meTXvkvZb2rVIJTOBwpfHlxBjWZN-CYbmevNeBoWKW81bKSvs050IAlSZiGEZp4SehF6RhNw7SPlGOeMG_MfDROvV44CNN35EU-ovFwNGAzHYVCFeAC7gOW0r6pqJn_XX4-jXdJ71xCPV_l8gqQ7QiLC0uZ-5kgS5cshJDcJZLzJ1uxuN2E1j5M1_vBN3BSbsvKCIxbUC--vuWtUr8Fv9Nc-wX_HYNO |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQGlb8UuSzv7MKTrB632Y3Rxm09jzVIQpBuu4r9vGjr1aW8hB8fl4HL53VcA7rssx5lpEDU3GFbJI-mpi6Wuq10j55xrC43JdEEUG_4reZ7pswZ8bHth5JzQbzkcUVgUE_Zeyvt6_RfEcmRt5eYhexdbqyePDhylRscYaybGijMcuKPESWzFtgVuU-JU0qofT01sCay01xegsJq0706GVV_K-r9T8Y5gfyT4FeUxNHjRhpa9_XutDQdRnfIWy9r6Nidge26aBjSI0cRKAyumYzQNqI8EME9da-w6aEytYRAG9A1ZsYPsJBqF7kxGoVBNOIU7z6W2rwpp5r-Hn0-T_6L3zqBZrAp-Dkg3mJYxTTz3c0aWJlkwxjOT8Czr60LF3Qvo7OJ0uZt8Cy2fRuE8DOKXKzisSFWVBMYdaJafX_xauOIyu5Ea_AFJL4Y5 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FERRITIN+VARIANTS+WITH+INCREASED+STABILITY+AND+COMPLEXATION+ABILITY&rft.inventor=BONAMORE%2C+Alessandra&rft.inventor=MARSZALEK%2C+Ilona&rft.inventor=SKORZYNSKI%2C+Marcin&rft.inventor=KROL%2C+Magdalena&rft.inventor=BOFFI%2C+Alberto&rft.inventor=RYGIEL%2C+Tomasz&rft.inventor=ARCOVITO%2C+Alessandro&rft.date=2022-09-22&rft.externalDBID=A1&rft.externalDocID=WO2022195092A1 |